CapsoVision
CV on Nasdaq. CapsoVision sells camera capsules and software to doctors for examining the gut. Market value $330m.
Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to December 2025.
We can't read total debt from the filing, so debt is left out.
Should I look at this?
Look carefully before going further
Why it could be worth it
Nothing stands out yet.
Read the warning sign in its own filings
This is not advice. Check the numbers below.
For every $100 of what the whole company costs, it produced $-8.57 of spare cash in the past 12 months. A savings account pays about $4.
The filings do not give us enough to work this out.
The filings do not give us enough to work this out.
Quality score: not known. Price score: 0 of 100. Our list needs 70 on quality and 60 on price.
$6.50 a share, 48% above its 1-year low
Over the past year the price has ranged from $4.38 to $15.37.
Pays no dividend
Prices from Tuesday’s close (6 October).
Five years of cash, in billions
| Revenue | |
| Revenue | $14m |
| Operating margin | |
| Operating margin | -188.3% |
| Debt to equity | |
| Debt to equity | n/a |
| Shares outstanding | |
| Shares outstanding | 0.05bn |
Health checks
- Free cash flow positive0 of 1 years
- Accounting checksSkipped: company is not yet profitable
- DebtUnknown
- Revenue growth, five yearsUnknown
- Buying back its own sharesRoughly flat
The quarter to June 2026
How the business did, compared with the same quarter a year earlier.
- Sales: $4 million last quarter, up 10% on a year ago.
- A loss of $7 million, compared with a loss of $5 million a year ago.
- 2079% more shares than a year ago. Each share owns a bit less of the company.
| Quarter to | Amount |
|---|---|
| June 2025 | $3m |
| September 2025 | $4m |
| December 2025 | $4m |
| March 2026 | $3m |
| June 2026 | $4m |
| Quarter to | Amount |
|---|---|
| June 2025 | -$5m |
| September 2025 | -$8m |
| December 2025 | -$7m |
| March 2026 | -$7m |
| June 2026 | -$7m |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- n/a
- Last annual report (10-K)
- 26 March 2026
- Next quarterly (estimated, 10-Q)
- 12 November 2026
Who owns it
None of the long-term investors we follow own it. 50 funds in all.
Largest holders overall
- BlackRock$14mAdded
- Vanguard Capital Management$8mAdded
- Geode Capital Management$4mAdded
- State Street$3mAdded
- Vanguard Portfolio Management$2mAdded
- Northern Trust$2mAdded
- Vanguard Fiduciary Trust$785,515Added
- Charles Schwab Investment Management$601,549Added
- Bank of New York Mellon$568,657Added
- Nuveen$348,763Added
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
3 investors own more than 5%.
- Shen Ching HangPassive investorat least 12.8%+4.3 pts(filed with 1 related holder)Since 10 April 2026
- Eliyahou HarariPassive investorat least 10.2%+1.0 pts(filed with 4 related holders)Since 16 March 2026
- Kioxia CorporationPassive investorat least 7.4%(filed with 1 related holder)Since 1 July 2025
- CID Greater China Venture Capital Fund III, L.P.Passive investorSold down below 5%Since 31 March 2026
| Holder | Stake | Since | |
|---|---|---|---|
Shen Ching Hang Passive investor | at least 12.8%+4.3 pts (filed with 1 related holder) | 10 April 2026 | |
Eliyahou Harari Passive investor | at least 10.2%+1.0 pts (filed with 4 related holders) | 16 March 2026 | |
Kioxia Corporation Passive investor | at least 7.4% (filed with 1 related holder) | 1 July 2025 | |
CID Greater China Venture Capital Fund III, L.P. Passive investor | Sold down below 5% | 31 March 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
No insider bought shares on the open market in the last 12 months. 1 sold $8,587.
- Imperial Joanne CarolDirectorSold
- Date
- 8 June 2026
- Shares
- 1,200
- Price
- $7.16
- Value
- $8,587
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 8 June 2026 | Imperial Joanne Carol Director | Sold | 1,200 | $7.16 | $8,587 |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
2 serious warning signs in CapsoVision’s filings.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 26 Mar 2026, plus the 10-Q filed 13 Aug 2026 and 7 later 8-Ks.
Doubt it can keep going
SeriousThe company or its auditor warned it may not have enough money to last the next year.
“Our interim (unaudited) financial statements for the six months ended June 30, 2026 included in this Quarterly Report on Form 10-Q note that there is substantial doubt about our ability to continue as a going concern within one year after the date of issuance of those financial statements (see Note 2.”
Show the full paragraph
Our interim (unaudited) financial statements for the six months ended June 30, 2026 included in this Quarterly Report on Form 10-Q note that there is substantial doubt about our ability to continue as a going concern within one year after the date of issuance of those financial statements (see Note 2. GOING CONCERN). This means that we have expressed substantial doubt about our ability to continue our operations without an additional infusion of capital from external sources. Our interim (unaudited) financial statements have been prepared on a going concern basis and do not include any adjustments to reflect the future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may be necessary should we be unable to continue as a going concern. If we are unable to finance our operations, our business would be in jeopardy and we might not be able to continue operations and might have to liquidate our assets. In that case, investors might receive less than the value at which those assets are carried on our interim (unaudited) financial statements for the six months ended June 30, 2026, and it is likely that investors would lose all or a part of their investment. See “Risk Factors—Business and Industry Risks—Our Quarterly Report, our unaudited financial statements for the six months ended June 30, 2026 and our audited financial statements for the year ended December 31, 2025 include a footnote raising substantial doubt about our ability to continue as a ‘going concern’ and we will likely need to raise additional financing to fund our business and revenue growth plans."
From the 10-Q filed 13 August 2026, Part I, Item 2. Management's Discussion and Analysis. Read it in the filing
Weak checks on its own accounts
SeriousThe company said its checks on its own accounts did not work at the end of its latest quarter. Mistakes could slip into the numbers.
“Based on our management’s evaluation (with the participation of our principal executive officer and our principal financial officer) of our disclosure controls and procedures as required by Rule 13a-15 under the Exchange Act and the material weaknesses previously identified and further discussed below, our principal executive officer and our principal financial officer have concluded that our disclosure controls and procedures were not effective at the reasonable level of assurance as of June 30, 2026, the end of the period covered by this Quarterly Report on Form 10-Q.”
Show the full paragraph
Based on our management’s evaluation (with the participation of our principal executive officer and our principal financial officer) of our disclosure controls and procedures as required by Rule 13a-15 under the Exchange Act and the material weaknesses previously identified and further discussed below, our principal executive officer and our principal financial officer have concluded that our disclosure controls and procedures were not effective at the reasonable level of assurance as of June 30, 2026, the end of the period covered by this Quarterly Report on Form 10-Q. Please see below for the disclosure of the Company's material weaknesses in internal control and the remediation plan.
From the 10-Q filed 13 August 2026, Part I, Item 4. Controls and Procedures. Read it in the filing
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
What could go wrong
Cheap for a reason is the question the numbers cannot answer.
Whether the price already reflects the risks is what the deep dive is for.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.